Journal article
The global impact and cost-effectiveness of a melioidosis vaccine
- Abstract:
-
Background Every year, 90,000 people may die from melioidosis. Vaccine candidates have not proceeded past animal studies, partly due to uncertainty around the potential market size. This study aims to estimate the potential impact, cost-effectiveness and market size for melioidosis vaccines.
Methods Age-structured decision tree models with country-specific inputs were used to estimate net costs and health benefits of vaccination, with health measure...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Springer Publisher's website
- Journal:
- BMC Medicine Journal website
- Volume:
- 17
- Article number:
- 129
- Publication date:
- 2019-07-05
- Acceptance date:
- 2019-06-04
- DOI:
- EISSN:
-
1741-7015
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:1028311
- UUID:
-
uuid:a822c995-5179-4208-a309-24e5d07e2580
- Local pid:
- pubs:1028311
- Source identifiers:
-
1028311
- Deposit date:
- 2019-07-07
Terms of use
- Copyright holder:
- Luangasanatip et al
- Copyright date:
- 2019
- Notes:
- © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record